P2Y2 Receptor Induces L. amazonensis Infection Control in a Mechanism Dependent on Caspase-1 Activation and IL-1β

Maria Luiza Thorstenberg1, Monique Daiane Andrade Martins1, Vanessa Figliuolo1

  • 1Laboratório de Imunofisiologia, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Mediators of Inflammation
|October 16, 2020
PubMed

Insights

Activation of the P2Y2 receptor helps control Leishmania amazonensis infection by triggering caspase-1 and IL-1β secretion. This pathway is crucial for the immune response against cutaneous leishmaniasis.

Area of Science:

  • Immunology
  • Parasitology
  • Tropical Diseases

Background:

  • Leishmaniasis is a neglected tropical disease caused by Leishmania parasites.
  • Damage-associated molecular patterns (DAMPs) like UTP and ATP activate P2 purinergic receptors on host cells.
  • P2Y2 and P2X7 receptors play a role in controlling Leishmania amazonensis infection, with P2X7 activation leading to NLRP3 inflammasome activation and IL-1β release.

Purpose of the Study:

  • To investigate the role of the P2Y2 receptor in NLRP3 inflammasome activation, caspase-1/11 and IL-1β secretion.
  • To determine the involvement of P2Y2 receptor signaling in controlling Leishmania amazonensis infection in macrophages and a murine model of cutaneous leishmaniasis.

Main Methods:

  • Murine peritoneal macrophages and a murine model of cutaneous leishmaniasis were used.
  • Experiments involved treatment with P2Y2 agonists (2-thio-UTP, UTP) and antagonists.
  • Caspase-1/11 knockout mice (CASP-1,11-/-) and caspase-1 inhibitor (Z-YVAD-FMK) were utilized to assess the role of caspase-1.
  • IL-1 receptor antagonist was used to block IL-1β signaling.

Main Results:

  • P2Y2 receptor activation by 2-thio-UTP reduced Leishmania amazonensis parasite load in macrophages and in vivo.
  • Antiparasitic effects were dependent on caspase-1 activity, as they were abolished in CASP-1,11-/- mice and when caspase-1 was inhibited.
  • UTP treatment induced IL-1β secretion in wild-type macrophages but not in CASP-1,11-/- macrophages.
  • In vivo, UTP treatment reduced parasite load and lesion size in wild-type mice but not in CASP-1,11-/- mice.
  • Blocking IL-1R signaling abrogated the protective effects of P2Y2 activation.

Conclusions:

  • P2Y2 receptor activation triggers caspase-1 activation and subsequent IL-1β secretion during Leishmania amazonensis infection.
  • IL-1β/IL-1R signaling is essential for the protective immune response mediated by the P2Y2 receptor in experimental cutaneous leishmaniasis.